Big Pharma spends big to block attempts to control drug prices

The Biden administration and Congress are embroiled in high-stakes haggling over what urgent priorities will make it into the ever-shrinking social spending bill. But for the pharmaceutical industry there is one agenda: Heading off Medicare drug price negotiation, which it considers an existential threat to its business model. The siren call to contain rising drug costs helped catapult Democrats to power, and the idea is popular among voters regardless of their politics.

Read the source article at Tampa Bay, Florida news
2021-10-27 21:12:47